Understanding how genetic and environmental factors affect resistance to cancer treatment in esophageal adenocarcinoma
Role of genomic and microenvironment factors in conferring acquired resistance to ferroptosis to chemoradiation in esophageal adenocarcinoma
This study is looking into why some people with esophageal adenocarcinoma don’t respond well to chemoradiation therapy, by examining their tumor samples to find out what genetic and environmental factors might be making the treatment less effective, with the hope of improving future treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10917384 on NIH RePORTER |
What this research studies
This research investigates the reasons why some patients with esophageal adenocarcinoma do not respond to chemoradiation therapy. By analyzing tumor samples collected from patients before and during treatment, the study aims to identify specific genetic and environmental factors that contribute to resistance against a type of cell death called ferroptosis, which is important for the effectiveness of the therapy. The researchers will use advanced techniques like single cell transcriptome profiling to explore the interactions between cancer cells and their surrounding environment, providing insights that could lead to better predictive tools for treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with esophageal adenocarcinoma who are about to undergo chemoradiation therapy.
Not a fit: Patients with other types of cancer or those who are not undergoing chemoradiation therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for patients with esophageal adenocarcinoma, enhancing their chances of responding to therapy.
How similar studies have performed: Other research has shown promise in understanding cancer treatment resistance through similar genomic and microenvironmental analyses, indicating that this approach could yield valuable insights.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Lin, Steven Hsesheng — University of Tx Md Anderson Can Ctr
- Study coordinator: Lin, Steven Hsesheng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.